Investing in mRNA Technologies

David Maza, Managing Director and Head of Product at Direxion, joins Cheddar News to discuss the evolution of mRNA technologies, future applications of this tech including fighting Lyme disease and HIV, and what this all means for investors.

Jun 16, 2022

More Videos

This Company Wants to Halve Your Heating Bill and Emissions

With buildings responsible for over 40% of emissions worldwide, the CEO of Kelvin breaks down how its technology can be used to retrofit traditional radiators.

Meet Stagflation: It Might Even be Worse Than a Recession

After battling inflation for years, now U.S. consumers have to prepare for stagflation, and, unfortunately, it could be more complicated to fix than a typical

Lightspeed Partner Talks Early Investment In Rubrik

Lightspeed co-foudner, Ravi Mhatre, sits down with Cheddar the NYSE to discuss why it invested in Rubrik early on and celebrates the company's IPO.

How Elf Labs Is Reimagining Some Of Your Favorite Fictional Characters

Elf Labs CEO, David Phillips, speaks to Cheddar about how the company came to be and how it is bringing forth fairytale characters in new and exciting ways.

Uh Oh: The U.S. Economy Has Signs of a ‘Mild’ Recession

Don’t panic just yet, but it's starting to look like the economy is slowing down… AKA heading into what one analyst calls a ‘mild form of a recession.’

How Certainly Health Makes Medical Bills More Transparent

CEO of Certainly Health, Kevin Chiu, joins Cheddar to discuss how his company aims to make what is in your medical bills more transparent.

From Boeing to Meta: The Highs and Lows of Earnings Season (So Far)

With 40% of the S&P 500 reporting earnings this week, Cheddar correspondent Alison Kosik breaks down the highlights.

Not All A.I. Stocks Are Created Equally

With every company touting their new A.I. projects, one analyst cautions investors not all companies will grow as much as Nvidia.

Trending Now